| Title | Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting |
| Authors | Luo, Feng Roger Ding, Jian Chen, Helen X. Liu, Hao Fung, Man-Cheong Koehler, Maria Armand, Jean Pierre Jiang, Lei Xu, Xiao Zhang, Ge Xu, Li Qian, Pascal Yan, Li |
| Affiliation | US Chinese Anticanc Assoc, Martinez, CA 94553 USA. Janssen Res & Dev LLC, Dept Oncol, Raritan, NJ 08869 USA. Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China. NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA. Novartis Pharmaceut China Oncol, Beijing 10004, Peoples R China. Pfizer Oncol, New York, NY 10017 USA. Inst Gustave Roussy, F-94805 Villejuif, France. ACEA Biosci Inc, San Diego, CA 92121 USA. Jiangsu Hengrui Med Co Ltd, Shanghai 200122, Peoples R China. Peking Univ, Beijing Canc Hosp & Inst, Sch Oncol, Beijing 100142, Peoples R China. |
| Keywords | Breakthrough clinical trial cancer medicine CELL LUNG-CANCER GASTRIC-CANCER BREAST-CANCER INHIBITOR PCI-32765 IBRUTINIB |
| Issue Date | 2014 |
| Publisher | 癌症 |
| Citation | CHINESE JOURNAL OF CANCER.2014,33,(12),620-624. |
| Abstract | The US Chinese Anti-Cancer Association (USCACA) teamed up with Chinese Society of Clinical Oncology (CSCO) to host a joint session at the 17th CSCO Annual Meeting on September 20th, 2014 in Xiamen, China. With a focus on breakthrough cancer medicines, the session featured innovative approaches to evaluate breakthrough agents and established a platform to interactively share successful experiences from case studies of 6 novel agents from both the United States and China. The goal of the session is to inspire scientific and practical considerations for clinical trial design and strategy to expedite cancer drug development in China. A panel discussion further provided in-depth advice on advancing both early and full development of novel cancer medicines in China. |
| URI | http://hdl.handle.net/20.500.11897/387869 |
| ISSN | 1000-467X |
| DOI | 10.5732/cjc.014.10246 |
| Indexed | SCI(E) 中国科技核心期刊(ISTIC) |
| Appears in Collections: | 北京肿瘤医院 |
